Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionLantz Financial LLC
Latest Disclosed Ownership7,900 shares
Latest Disclosed Value $ 1,206,725
Lantz Financial LLC reports 20.76% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 9, 2026 - Lantz Financial LLC filed a 13F-HR form disclosing ownership of 7,900 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $1,015,150 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 6,542 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 20.76% during the quarter. The current value of the position is $955,900 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,900 1,358 20.76 1,207 33.85 0.2495
2026-01-14 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,542 -219 -3.24 902 3.92 0.1903
2025-11-06 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,761 134 2.02 867 8.24 0.1919
2025-07-11 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 6,627 17 0.26 802 8.83 0.1999
2025-04-08 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 6,610 132 2.04 737 16.83 0.2017
2025-01-21 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 6,478 -384 -5.60 630 -20.15 0.1680
2024-10-15 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 6,862 -199 -2.82 789 5.06 0.2137
2024-08-07 2024-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 7,061 -133 -1.85 752 8.06 0.2335
2024-07-10 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,061 -133 752 0.2335
2024-04-10 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,194 -265 -3.55 696 -7.70 0.2239
2024-01-12 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 7,459 9 0.12 753 -0.66 0.2720
2023-10-20 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 7,450 28 0.38 759 1.34 0.3019
2023-07-12 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 7,422 -384 -4.92 749 4.18 0.2933
2023-04-10 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 7,806 -248 -3.08 718 -1.64 0.2987
2023-01-23 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 8,054 -49 -0.60 731 18.51 0.3323
2022-10-17 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 8,103 -750 -8.47 616 -17.65 0.3205
2022-07-29 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 8,853 547 6.59 748 2.89 0.3376
2022-01-19 2021-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,306 -184 -2.17 727 4.76 0.3348
2021-10-14 2021-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 8,490 403 4.98 694 -5.96 0.3558
2021-07-16 2021-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 8,087 -86 -1.05 738 5.58 0.3793
2021-04-19 2021-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,173 77 0.95 699 -8.63 0.3976
2021-01-19 2020-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,096 244 3.11 765 12.01 0.4773
2020-10-09 2020-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 7,852 72 0.93 683 0.44 0.4593
2020-07-22 2020-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 7,780 -1,606 -17.11 680 -12.14 0.4894
2020-04-10 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 9,386 1,031 12.34 774 -2.15 0.6065
2020-01-17 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,355 -545 -6.12 791 5.33 0.4683
2019-10-18 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 8,900 -518 -5.50 751 -13.38 0.5068
2019-07-15 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,418 -179 -1.87 867 -6.07 0.5869
2019-04-22 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 9,597 9,597 923 0.6694
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.